Ambu®AuraGain™ Versus I-gel® in Obese Patients (NCT03110393) | Clinical Trial Compass
CompletedNot Applicable
Ambu®AuraGain™ Versus I-gel® in Obese Patients
Switzerland44 participantsStarted 2017-04-20
Plain-language summary
The aim of this study is the randomized comparison of two laryngeal mask (Intersurgical i-gel® and Ambu®AuraGain™) in obese patients
Who can participate
Age range18 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* ASA 1-3
* Shoulder-/Elbow-/Hip-/Knee- or Foot - Surgery
* Signed informed consent
* BMI \> 35kg/m2
Exclusion Criteria:
* Non-sober patients (last meal \<6 h)
* Symptomatic reflux disease
* Hiatus hernia
* Significant cardiovascular risk factors
* Severe COPD
* Gastric band or gastric bypass
* Disease which allows an accurate examination of the physicians (e.g. neuromuscular, mental, metabolic disease)
* Drug or drug abuse in the recent past
* Legal immaturity (incompetence)
* Acute disease, which calls into question the narcotic potential
* Patients with whom the use of a laryngeal mask is contraindicated or otherwise not possible